Small Molecules, ADCs
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
271
NCT03657550
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2018
Completion: Sep 6, 2018
NCT03553914
PLM60 for Peripheral T Cell Lymphoma (PTCL)
Phase: Phase 1/2
Start: Jan 31, 2021
Completion: Jan 31, 2025
NCT04931823
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Start: Mar 24, 2021
Completion: Mar 1, 2025
NCT03567694
Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers
Start: Oct 1, 2021
Completion: Oct 12, 2022
NCT04853329
Dose Escalation and Expansion Study of CPO107 for Patients with Advanced CD20-positive Non-Hodgkins Lymphoma
Start: Dec 13, 2021
Completion: Jan 31, 2023
NCT05043987
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers
Start: Nov 16, 2022
Completion: Nov 16, 2022
NCT05948865
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Start: Jun 6, 2023
Completion: Dec 12, 2025
NCT04675450
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Phase: Phase 2
Start: Jun 30, 2023
Completion: Jan 30, 2025
Loading map...